We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $480M
1-Year Est. Return 77.45%
This Fund
S&P 500
This Quarter Est. Return
+31.78%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
10 Year Est. Return
AUM
$464M
AUM Growth
+$79.9M
Cap. Flow
-$8.95M
Cap. Flow %
-1.93%
Top 10 Hldgs %
81.5%
Holding
63
New
7
Increased
24
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$16.4M
2
TSLA icon
Tesla
TSLA
+$6.63M
3
BIIB icon
Biogen
BIIB
+$2.55M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.68M
5
AMZN icon
Amazon
AMZN
+$1.58M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$19.9M
2
SNOW icon
Snowflake
SNOW
+$7.13M
3
NET icon
Cloudflare
NET
+$6.76M
4
SWTX
SpringWorks Therapeutics
SWTX
+$5.47M
5
CPNG icon
Coupang
CPNG
+$1.83M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30.56%
2 Technology 23.32%
3 Healthcare 20.84%
4 Communication Services 18.3%
5 Financials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPOT icon
1
Spotify
SPOT
$105B
$84.8M 18.3%
114,000
-31,000
-21% -$19.9M
TSLA icon
2
Tesla
TSLA
$1.21T
$74.7M 16.11%
242,000
+22,000
+10% +$6.63M
SHOP icon
3
Shopify
SHOP
$169B
$49M 10.57%
430,000
+15,000
+4% +$1.5M
PLTR icon
4
Palantir
PLTR
$296B
$46.6M 10.05%
350,000
-10,000
-3% -$1.17M
AMZN icon
5
Amazon
AMZN
$2.48T
$32.8M 7.07%
149,000
+8,000
+6% +$1.58M
SE icon
6
Sea Limited
SE
$65.8B
$32.5M 7.01%
210,000
COIN icon
7
Coinbase
COIN
$44.2B
$24.2M 5.22%
+70,000
New +$16.4M
NVDA icon
8
NVIDIA
NVDA
$4.77T
$12.5M 2.7%
81,000
+8,000
+11% +$1.01M
IONS icon
9
Ionis Pharmaceuticals
IONS
$9.14B
$10.7M 2.31%
267,594
PRQR icon
10
ProQR Therapeutics
PRQR
$248M
$10M 2.17%
4,997,562
+11,929
+0.2% +$19.4K
ARWR icon
11
Arrowhead Research
ARWR
$12.1B
$9.85M 2.13%
612,214
-17,000
-3% -$244K
RARE icon
12
Ultragenyx Pharmaceutical
RARE
$2.56B
$9.18M 1.98%
253,304
+3,500
+1% +$126K
QURE icon
13
uniQure
QURE
$2.52B
$6.26M 1.35%
447,486
-131,653
-23% -$1.77M
AXSM icon
14
Axsome Therapeutics
AXSM
$12.1B
$5.43M 1.17%
52,732
MRK icon
15
Merck
MRK
$326B
$4.83M 1.04%
59,093
+18,000
+44% +$1.43M
ARQT icon
16
Arcutis Biotherapeutics
ARQT
$3.55B
$4.74M 1.02%
344,472
+18,763
+6% +$263K
ZLAB icon
17
Zai Lab
ZLAB
$2.1B
$4.65M 1%
132,189
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$124B
$3.75M 0.81%
8,300
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.45B
$3.17M 0.68%
148,400
MRNA icon
20
Moderna
MRNA
$22.1B
$2.97M 0.64%
103,433
+27,857
+37% +$734K
BIIB icon
21
Biogen
BIIB
$30.4B
$2.67M 0.58%
+20,500
New +$2.55M
CRSP icon
22
CRISPR Therapeutics
CRSP
$4.68B
$2.17M 0.47%
44,700
-15,397
-26% -$596K
ABEV icon
23
Ambev
ABEV
$48.4B
$1.93M 0.42%
795,786
-8,420
-1% -$20.5K
CVNA icon
24
Carvana
CVNA
$47.3B
$1.68M 0.36%
+25,000
New +$1.37M
URGN icon
25
UroGen Pharma
URGN
$1.99B
$1.4M 0.3%
107,622

Similar funds

Privium Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, Privium Fund Management held 63 positions worth $464M, up 21% from $384M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Privium Fund Management's Q2 2025 filing shows 7 new, 24 increased, 7 reduced and 8 closed positions. Its largest new stake was Coinbase: 70,000 shares worth $24.2M. The largest sale was Spotify, an estimated $19.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • Privium Fund Management's largest Q2 2025 buy was Coinbase: 70,000 shares worth $24.2M.
  • Privium Fund Management added most to Tesla in Q2 2025, an estimated $6.63M increase.
  • Privium Fund Management's biggest Q2 2025 reduction was Spotify, cutting an estimated $19.9M.
  • Privium Fund Management fully exited Snowflake in Q2 2025, selling an estimated $7.13M.
  • Privium Fund Management's ten largest holdings make up 82% of its $464M portfolio in Q2 2025.
  • Privium Fund Management opened 7 new positions and closed 8 in Q2 2025.
  • Privium Fund Management's portfolio value rose 21% quarter-over-quarter to $464M.

Based on Privium Fund Management's 13F filing for Q2 2025, filed 30 Jul 2025.